Floatz logo

Therapeutic Asset Ratings

409 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Nrm-823
Ovarian Cancer
Normunity AccelCo, Inc.P1C (36)
Nuv-868
Ovarian Cancer
Nuvation Bio Inc.P1C (36)
nxp800
Ovarian Cancer
Nuvectis Pharma, Inc.P1C (36)
Obinutuzumab
Ovarian Cancer
NeoTX Therapeutics Ltd.P1C (36)
OPB-201
Ovarian Cancer
Outpace Bio, Inc.P1C (36)
Ovm-200
Ovarian Cancer
Oxford Vacmedix UK Ltd.P1C (36)
Pcna Inhibitor Aoh1996
Ovarian Cancer
City of Hope Medical CenterP1C (36)
pf-07224826
Ovarian Cancer
PfizerP1C (36)
pf-07263689
Ovarian Cancer
PfizerP1C (36)
Phn-010
Ovarian Cancer
Pheon TherapeuticsP1C (36)
Phst001
Ovarian Cancer
Pheast TherapeuticsP1C (36)
PITTSBURGH COMPOUND B UNLABELLED
Ovarian Cancer
University of Alabama at BirminghamP1C (36)
P-Muc1C-Allo1 Car-T Cells
Ovarian Cancer
Poseida Therapeutics, Inc.P1C (36)
QXL138AM
Ovarian Cancer
Nammi Therapeutics IncP1C (36)
rad301
Ovarian Cancer
Radiopharm Theranostics, LtdP1C (36)
Rgt-490
Ovarian Cancer
Regor Pharmaceuticals Inc.P1C (36)
Rimiducid
Ovarian Cancer
Poseida Therapeutics, Inc.P1C (36)
Sct-001 Car-T Cells
Ovarian Cancer
Shanghai Gynecologic Oncology GroupP1C (36)
Slv-154
Ovarian Cancer
Solve TherapeuticsP1C (36)
Son-Dp
Ovarian Cancer
Qurgen Inc.P1C (36)
syn608
Ovarian Cancer
Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdP1C (36)
syn818
Ovarian Cancer
Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdP1C (36)
Synkir-110, Autologous T Cells Transduced With Mesothelin Kir-Car
Ovarian Cancer
Verismo TherapeuticsP1C (36)
sys6043
Ovarian Cancer
Conjupro Biotherapeutics, Inc.P1C (36)
Tbi-1301
Ovarian Cancer
University Health Network, TorontoP1C (36)
Showing 351 to 375 of 409 assets
PreviousPage 15 of 17Next